Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control

Neus Carbó1, Joaquı́n López-Soriano1, Paola Costelli2, Belén Alvarez1, Sı́lvia Busquets1, Francesco M Baccino2,3, LeBris S Quinn4,5, Francisco J López-Soriano1, Josep M Argilés1
1Cancer Research Group, Departament de Bioquı́mica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, 08071 Barcelona, Spain
2Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Turin, Italy
3CNR Center of Immunogenetics and Experimental Oncology, Turin, Italy
4Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, American Lake Division, Tacoma, WA 98493, USA
5Department of Medicine, University of Washington, Seattle, WA 98195, USA

Tài liệu tham khảo

Grabstein, 1994, Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor, Science, 264, 965, 10.1126/science.8178155 Bruton, 1994, A lymphokine, provisionally designated interleukin T and produced by a human adult T cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells, Proc. Natl. Acad. Sci. USA, 91, 4935, 10.1073/pnas.91.11.4935 Carson, 1994, Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J. Exp. Med., 180, 1395, 10.1084/jem.180.4.1395 Armitage, 1995, IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation, J. Immunol., 154, 483, 10.4049/jimmunol.154.2.483 Akbar, 1996, IL-2 receptor common γ-chain signaling cytokines regulate activated T-cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression, Eur. J. Immunol., 26, 294, 10.1002/eji.1830260204 Girard, 1996, Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15, Blood, 88, 3176, 10.1182/blood.V88.8.3176.bloodjournal8883176 Giri, 1994, Utilization of the β and γ chain of the IL-2 receptor by the novel cytokine IL-15, EMBO J., 13, 2822, 10.1002/j.1460-2075.1994.tb06576.x Quinn, 1995, Interleukin-15: a novel anabolic cytokine for skeletal muscle, Endocrinology, 136, 3669, 10.1210/en.136.8.3669 Quinn, 1997, Interleukin-15 stimulates C2 skeletal myoblast differentiation, Biochem. Biophys. Res. Commun., 239, 6, 10.1006/bbrc.1997.7414 Tessitore, 1987, Early development of protein metabolic perturbations in the liver and skeletal muscle of tumor-bearing rats. A model system for cancer cachexia, Biochem. J., 241, 153, 10.1042/bj2410153 Tessitore, 1993, Humoral mediation for cachexia in tumor-bearing rats, Br. J. Cancer, 67, 15, 10.1038/bjc.1993.4 Swick, 1974, Measurement of protein turnover in rat liver with [14C]carbonate. Protein turnover during liver regeneration, J. Biol. Chem., 249, 6836, 10.1016/S0021-9258(19)42134-0 MacDonald, 1979, A comparison of methods for the measurement of protein turnover in vitro, Biochem. J., 184, 473, 10.1042/bj1840473 Garlick, 1975, The effect of protein deprivation and starvation on the rate of protein synthesis in tissues of the rat, Biochim. Biophys. Acta, 414, 71, 10.1016/0005-2787(75)90126-4 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 M.W. Slein, d-Glucose determination with hexokinase and glucose-6-phosphate dehydrogenase, in: H.U. Bergmeyer (Ed.), Methods of Enzymatic Analysis, Academic Press, New York, 1963, pp. 117–123. I. Gutmann, A.W. Wahlefeld, l-(+)-Lactate: determination with lactate dehydrogenase and NAD, in: H.U. Bergmeyer (Ed.), Methods of Enzymatic Analysis, Academic Press, New York, 1974, pp. 1464–1468. Eggstein, 1966, A new method for the determination of neutral fats in blood serum and tissues, Klin. Wochenschr., 44, 262, 10.1007/BF01747716 Havel, 1955, Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 Nilsson-Ehle, 1977, Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase, Artery, 3, 197 Nilsson-Ehle, 1976, A stable, radioactive substrate emulsion for assay of lipoprotein lipase, J. Lipid Res., 17, 536, 10.1016/S0022-2275(20)41752-3 Robinson, 1978, Evidence for a role of insulin in the regulation of lipogenesis in lactating rat mammary gland, Biochem. J., 176, 343, 10.1042/bj1760343 Stansbie, 1986, Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats, Biochem. J., 160, 413, 10.1042/bj1600413 López-Soriano, 1995, Metabolic effects of tumour necrosis factor-α on rat brown adipose tissue, Mol. Cell. Biochem., 143, 113, 10.1007/BF01816944 J.D. Lee, T.D. Lee, in: Statistic and Numerical Methods for Biologists, vol. 1, Van Nostrand Reinhold Company, 1982, pp. 185–205. Llovera, 1993, Effects of tumour necrosis factor-α on muscle protein turnover in female Wistar rats, J. Natl. Cancer Inst., 85, 1334, 10.1093/jnci/85.16.1334 D.H. Williamson, Regulation of adipose tissue mass and metabolism, in: N.J. Rothwell, M.J. Stock (Eds.), Obesity and Cachexia, John Wiley and Sons, New York, 1991, pp. 63–101. Gibbons, 1990, Assembly and secretion of hepatic very low density lipoproteins, Biochem. J., 268, 1, 10.1042/bj2680001 Argilés, 1992, The role of cytokines in muscle wasting: its relation with cancer cachexia, Med. Res. Rev., 12, 637, 10.1002/med.2610120605 Grunfeld, 1990, Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon alpha, Endocrinology, 127, 46, 10.1210/endo-127-1-46 Grunfeld, 1990, Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin-6, Cancer Res., 50, 4233 Grunfeld, 1992, Tumor necrosis factor, interleukin and interferon induced changes in lipid metabolism as part of host defense, Proc. Soc. Exp. Biol. Med., 200, 224, 10.3181/00379727-200-43424 Price, 1986, Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor: the primary regulatory role of the hormone in 3T3-L1 adipocytes, Arch. Biochem. Biophys., 251, 738, 10.1016/0003-9861(86)90384-X Porat, 1989, The effect of tumor necrosis factor-α on the activity of lipoprotein lipase in adipose tissue, Lymphokine Res., 4, 459 Argilés, 1989, Interleukin-1 and lipid metabolism in the rat, Biochem. J., 259, 673, 10.1042/bj2590673 Grunfeld, 1990, Tumour necrosis factor: immunologic, antitumor, metabolic and cardiovascular activities, Adv. Intern. Med., 35, 45 Argilés, 1989, The obese Zucker rat: a choice for fat metabolism. 1968–1988: twenty years of research on the insights of the Zucker mutation, Prog. Lipid Res., 2, 53, 10.1016/0163-7827(89)90007-6 Muoio, 1997, Leptin directly alters lipid partitioning in skeletal muscle, Diabetes, 46, 1360, 10.2337/diabetes.46.8.1360 Hotamisligil, 1993, Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 Saghizadeh, 1996, The expression of TNF α by human muscle. Relationship to insulin resistance, J. Clin. Invest., 97, 1111, 10.1172/JCI118504 Garcia-Martı́nez, 1993, Tumour necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins, FEBS Lett., 323, 211, 10.1016/0014-5793(93)81341-V Garcia-Martı́nez, 1994, Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-α, Biochem. Biophys. Res. Commun., 201, 682, 10.1006/bbrc.1994.1754 Carbó, 2000, Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats, Br. J. Cancer, 83, 526, 10.1054/bjoc.2000.1299 Argilés, 1997, Journey from cachexia to obesity by TNF, FASEB J., 11, 743, 10.1096/fasebj.11.10.9271359 Carbó, 2000, Short-term effects of leptin on skeletal muscle protein metabolism in the rat, J. Nutr. Biochem., 11, 431, 10.1016/S0955-2863(00)00101-7